Malini Gupta

Malini Gupta, MD has a diverse work experience that includes roles such as Creative Consultant at AbbVie since 2023 and CEO & Founder of G2Endo since 2010. Malini has also worked as a Professional Speaker at Horizon and Eisai US, and as a Member of the Board of Directors at Consolidated Medical Practices of Memphis and Saint Francis Healthcare. Additionally, they served as the Secretary of the Board of Directors at the American Association of Clinical Endocrinologists. Prior to these positions, they held the roles of Professional Speaker at Eli Lilly and Company and Shire. Malini completed their medical training at the University of Tennessee Health Science Center, where they were an Endocrinology Fellow and an Internal Medicine Resident.

Malini Gupta, M.D. completed their education in a chronological order. Malini attended St. Mary's Episcopal School from 1982 to 1991 for their primary education. In 1991, they enrolled at Washington University in St. Louis, where they pursued a Bachelor of Arts (B.A.) degree in Biology and English Literature, graduating in 1995. Following this, they joined the University of Pennsylvania for a Post-baccalaureate Science Program in 1997, focusing on Neuroscience & Biochemistry. In 1998, they enrolled at University College Cork, where they graduated in 2003 with a Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.) degree in Medicine. During their time at University College Cork, they also pursued a Bachelor of Science (BSc) degree in Medicine from 1998 to 2000. Recently, in 2019 and 2020, they attended Harvard Medical School, where they obtained a Graduate Medical Education Certificate in Media & Medicine.